Regulation of Porcine Brain Alpha 2-adrenergic Receptors by Na+,H+ and Inhibitors of Na+/H+ Exchange
Overview
Affiliations
Previous reports from this laboratory have demonstrated that alpha 2-adrenergic receptors accelerate Na+/H+ exchange in NG108-15 neuroblastoma X glioma cells and evoke platelet secretion via a pathway involving Na+/H+ exchange. The present studies were designed to examine whether agents that interact with Na+/H+ antiporters also might influence alpha 2-adrenergic receptor-ligand interactions. We observed that Na+ decreases receptor affinity for the agonists epinephrine, norepinephrine, and UK14304 and slightly increases receptor affinity for the antagonists yohimbine and idazoxan in digitonin-solubilized preparations from porcine brain cortex. Increases in [H+] also decrease receptor affinity for agonists and cause either a slight increase or no change in receptor affinity for antagonists. Amiloride analogs accelerate the rate of [3H] yohimbine dissociation from digitonin-solubilized receptors with a relative effectiveness that parallels their ability to block Na+/H+ exchange in other systems. Interestingly, these modulatory effects of Na+,H+ and 5-amino-substituted analogs of amiloride are retained in homogeneous preparations of the alpha 2-adrenergic receptor, suggesting that the allosteric-binding sites for these agents are on the receptor-binding protein itself.
Massink A, Amelia T, Karamychev A, IJzerman A Med Res Rev. 2019; 40(2):683-708.
PMID: 31495942 PMC: 7028016. DOI: 10.1002/med.21633.
Involvement of tumor acidification in brain cancer pathophysiology.
Honasoge A, Sontheimer H Front Physiol. 2013; 4:316.
PMID: 24198789 PMC: 3814515. DOI: 10.3389/fphys.2013.00316.
Structural basis for allosteric regulation of GPCRs by sodium ions.
Liu W, Chun E, Thompson A, Chubukov P, Xu F, Katritch V Science. 2012; 337(6091):232-6.
PMID: 22798613 PMC: 3399762. DOI: 10.1126/science.1219218.
Kara E, Lin H, Svensson K, Johansson A, Strange P Br J Pharmacol. 2010; 161(6):1343-50.
PMID: 20804495 PMC: 3000658. DOI: 10.1111/j.1476-5381.2010.01010.x.
Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.
Lin H, Saisch S, Strange P Br J Pharmacol. 2006; 149(3):291-9.
PMID: 16921389 PMC: 2014272. DOI: 10.1038/sj.bjp.0706866.